Flossbach Von Storch’s BioNTech BNTX Stock Holding History

Flossbach Von Storch’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207M	Sell	2,226,138 -1,454,177	-40%	-$137M	0.94%	32
2026 Q1	$327M	Sell	3,680,315 -515,733	-12%	-$53M	1.53%	22
2025 Q4	$399M	Sell	4,196,048 -33,985	-0.8%	-$3.42M	1.58%	21
2025 Q3	$417M	Sell	4,230,033 -65	-0%	-$6.95K	1.64%	24
2025 Q2	$450M	Sell	4,230,098 -29,533	-0.7%	-$2.98M	1.84%	21
2025 Q1	$388M	Sell	4,259,631 -147,212	-3%	-$16.5M	1.68%	21
2024 Q4	$502M	Buy	4,406,843 +47,236	+1%	+$5.39M	2%	20
2024 Q3	$518M	Sell	4,359,607 -19,876	-0.5%	-$1.83M	2.03%	21
2024 Q2	$352M	Buy	4,379,483 +910,497	+26%	+$83.2M	1.48%	20
2024 Q1	$320M	Sell	3,468,986 -79,674	-2%	-$7.64M	1.39%	19
2023 Q4	$375M	Buy	3,548,660 +35,445	+1%	+$3.57M	1.71%	19
2023 Q3	$382M	Buy	3,513,215 +71,468	+2%	+$7.9M	1.68%	21
2023 Q2	$371M	Buy	3,441,747 +9,413	+0.3%	+$1.06M	1.5%	21
2023 Q1	$428M	Buy	3,432,334 +149,611	+5%	+$20.5M	1.8%	21
2022 Q4	$493M	Sell	3,282,723 -81,841	-2%	-$12.6M	1.88%	26
2022 Q3	$454M	Buy	3,364,564 +299,414	+10%	+$45.8M	1.67%	29
2022 Q2	$457M	Buy	3,065,150 +1,145,061	+60%	+$175M	1.53%	30
2022 Q1	$327M	Buy	+1,920,089	New	+$323M	0.91%	35

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Flossbach Von Storch's BNTX Position: Q2 2026 in Review

Flossbach Von Storch reduced its BioNTech (BNTX) stake by 40% in Q2 2026, selling an estimated $137M and leaving 2,226,138 shares worth $207M. The position accounts for 0.94% of the portfolio, ranked #32.

Flossbach Von Storch first reported a position in BNTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $518M in Q3 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Flossbach Von Storch held 2,226,138 shares of BioNTech worth $207M as of Q2 2026.
Flossbach Von Storch sold 1,454,177 BioNTech shares in Q2 2026, an estimated $137M.
BioNTech made up 0.94% of Flossbach Von Storch's portfolio in Q2 2026, its #32 holding.
Flossbach Von Storch first reported a position in BioNTech in Q1 2022 and has held it in 18 quarters since.
Flossbach Von Storch's BioNTech position peaked at $518M in Q3 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Flossbach Von Storch's 13F filing for Q2 2026, filed 10 Aug 2026.